While both Novo Nordisk Retatrutide and Durolane manage articular soreness, their mechanisms of action are significantly contrasting. Novo Nordisk's Retatrutide is a combined receptor affecting glucagon-like peptide-1 and glucose-dependent insulinotropic , primarily used for metabolic control , whic